Citation 83157

TSUKAMOTO,M: NAKAJIMA,S: ARAKAWA,H: SUGIURA,Y: SUZUKI,H: HIRAYAMA,M: KAMIYA,S: TESHIMA,Y: KONDO,H: KOJIRI,K: SUDA,H:. (1998). A NEW ANTITUMOR ANTIBIOTIC, BE-19412A, PRODUCED BY A STREPTOMYCETE.. 51(10)

Citation Details

TitleA NEW ANTITUMOR ANTIBIOTIC, BE-19412A, PRODUCED BY A STREPTOMYCETE.
AuthorsTSUKAMOTO,M: NAKAJIMA,S: ARAKAWA,H: SUGIURA,Y: SUZUKI,H: HIRAYAMA,M: KAMIYA,S: TESHIMA,Y: KONDO,H: KOJIRI,K: SUDA,H:
Year1998
Volume51
Issue10

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces species (STREPTOMYCETACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
STREPTOMYCES ANTIBIOTIC BE-19412-A
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
8
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
STREPTOMYCES ANTIBIOTIC BE-19412-A
.
9
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
10
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
11
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
12
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
13
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
14
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
15
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
16
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
ACTIVE
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
INACTIVE
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
INACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
INACTIVE
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-A
STRONG ACTIVITY
24Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
STREPTOMYCES ANTIBIOTIC BE-19412-B
None
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
27
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
ACTIVE
31
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
STREPTOMYCES ANTIBIOTIC BE-19412-B
.
32
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
33
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
34
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
35
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
36
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
37
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
38
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
39
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
40
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
41
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
42
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
43
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
44
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
45
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
46
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
47
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
48
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
INACTIVE
49
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC BE-19412-B
STRONG ACTIVITY
Show SPARQL Queries (1)